REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 43 filers reported holding REDHILL BIOPHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $74 | -100.0% | 528,673 | -15.3% | 0.00% | – |
| Q3 2022 | $314,000 | -3.1% | 623,892 | +67.3% | 0.00% | – |
| Q2 2022 | $324,000 | -28.3% | 372,930 | +113.0% | 0.00% | – |
| Q4 2021 | $452,000 | +283.1% | 175,058 | +938.7% | 0.00% | – |
| Q3 2019 | $118,000 | -72.4% | 16,853 | -74.3% | 0.00% | -100.0% |
| Q2 2019 | $427,000 | -47.9% | 65,677 | -33.3% | 0.00% | 0.0% |
| Q1 2019 | $819,000 | -51.1% | 98,532 | -67.3% | 0.00% | -66.7% |
| Q4 2018 | $1,674,000 | +6.8% | 301,693 | +69.9% | 0.00% | +50.0% |
| Q3 2018 | $1,568,000 | +606.3% | 177,621 | +582.0% | 0.00% | – |
| Q2 2018 | $222,000 | +318.9% | 26,045 | +152.3% | 0.00% | – |
| Q1 2018 | $53,000 | -75.0% | 10,324 | -47.3% | 0.00% | – |
| Q3 2017 | $212,000 | +19.1% | 19,585 | +42.2% | 0.00% | – |
| Q3 2015 | $178,000 | – | 13,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |